First study shows tie between probiotic and improved symptoms of depression

May 23, 2017

Probiotics may relieve symptoms of depression, as well as help gastrointestinal upset, research from McMaster University has found.

In a study published in the medical journal Gastroenterology (May 2), researchers of the Farncombe Family Digestive Health Research Institute found that twice as many adults with (IBS) reported improvements from co-existing depression when they took a specific probiotic than adults with IBS who took a placebo.

The study provides further evidence of the microbiota environment in the intestines being in direct communication with the brain said senior author Dr. Premysl Bercik, an associate professor of medicine at McMaster and a gastroenterologist for Hamilton Health Sciences.

"This study shows that consumption of a specific probiotic can improve both gut symptoms and psychological issues in IBS. This opens new avenues not only for the treatment of patients with functional bowel disorders but also for patients with primary psychiatric diseases," he said.

IBS is the most common gastrointestinal disorder in the world, and is highly prevalent in Canada. It affects the large intestine and patients suffer from abdominal pain and altered bowel habits like diarrhea and constipation. They are also frequently affected by chronic anxiety or depression.

The pilot study involved 44 adults with IBS and mild to moderate anxiety or depression. They were followed for 10 weeks, as half took a daily dose of the probiotic Bifidobacterium longum NCC3001, while the others had a placebo.

At six weeks, 14 of 22, or 64%, of the patients taking the probiotic had decreased depression scores, compared to seven of 22 (or 32%) of given placebo.

Functional Magnetic Resonance Imaging (fMRI) showed that the improvement in scores was associated with changes in multiple brain areas involved in mood control.

"This is the result of a decade long journey - from identifying the probiotic, testing it in preclinical models and investigating the pathways through which the signals from the gut reach the brain," said Bercik.

"The results of this are very promising but they have to be confirmed in a future, larger scale trial," said Dr. Maria Pinto Sanchez, the first author and a McMaster clinical research fellow.

The study was performed in collaboration with scientists from Nestlé.

Explore further: Intestinal bacteria alter gut and brain function

Related Stories

Intestinal bacteria alter gut and brain function

March 1, 2017
Research from McMaster University has found that bacteria in the gut impacts both intestinal and behavioural symptoms in patients suffering from irritable bowel syndrome (IBS), a finding which could lead to new microbiota-directed ...

Gastrointestinal disorders involve both brain-to-gut and gut-to-brain pathways

July 22, 2016
New research indicates that in patients with irritable bowel syndrome (IBS) or indigestion, there is a distinct brain-to-gut pathway, where psychological symptoms begin first, and separately a distinct gut-to-brain pathway, ...

New bowel disorder treatments needed, FDA says

April 17, 2017
(HealthDay)—There's no known cause or cure for irritable bowel syndrome (IBS), which affects more than 15 million Americans, according to the U.S. Food and Drug Administration.

Probiotics benefit in schizophrenia shaped by yeast infections

April 5, 2017
In a small pilot study of men with schizophrenia, researchers at Johns Hopkins Medicine and Sheppard Pratt Health System say they have evidence that adding probiotics—microorganisms, such as bacteria found in yogurts—to ...

New study finds link between depression and abnormal brain response to visceral pain in patients with IBS

October 2, 2014
High rates of anxiety and depression amongst patients with irritable bowel syndrome (IBS) have led many researchers to believe there could be a causal relationship between psychological factors and IBS symptoms. Now, scientists ...

Probiotics and the gut-brain axis

October 14, 2015
A recent study published in Brain, Behavior, and Immunity has found that intake of multispecies probiotics has a beneficial effect on cognitive reactivity to sad mood in a randomized controlled trial.

Recommended for you

Abusive avatars help schizophrenics fight 'voices': study

November 24, 2017
"You're rubbish. You're rubbish. You're a waste of space." The computer avatar pulls no punches as it lays into the young woman, a schizophrenia sufferer, facing the screen.

Ten-month-old infants determine the value of a goal from how hard someone works to achieve it

November 23, 2017
Babies as young as 10 months can assess how much someone values a particular goal by observing how hard they are willing to work to achieve it, according to a new study from MIT and Harvard University.

Domestic violence turns women off masculine men

November 23, 2017
Women who are afraid of violence within partnerships prefer more feminine men, according to new research carried out by scientists at the University of St Andrews.

Study finds infection and schizophrenia symptom link

November 22, 2017
If a mother's immune system is activated by infection during pregnancy, it could result in critical cognitive deficits linked to schizophrenia in her offspring, a University of Otago study has revealed.

Schizophrenia drug development may be 'de-risked' with new research tool

November 22, 2017
Researchers at Columbia University Medical Center (CUMC) and the New York State Psychiatric Institute (NYSPI) have identified biomarkers that can aid in the development of better treatments for schizophrenia.

Self-harm, suicide attempts climb among US girls, study says

November 21, 2017
Attempted suicides, drug overdoses, cutting and other types of self-injury have increased substantially in U.S. girls, a 15-year study of emergency room visits found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.